ANDA 62212, held by Glaxosmithkline. Ampicillin/Ampicillin Trihydrate.
As of Nov 16, 2026, ANDA 62212 (Totacillin), held by Glaxosmithkline, was first approved by FDA on Aug 2, 1979, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 2, 1979 | Original application | Approved | None posted |
| TotacillinEQ 250MG BASE · capsule;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| TotacillinEQ 500MG BASE · capsule;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Apr 20, 1998 | Supplement 5Manufacturing | Approved | None posted |
| Aug 2, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters